Literature DB >> 20373934

The diagnostic value of beta-human chorionic gonadotropin, progesterone, CA125 in the prediction of abortions.

M A Osmanağaoğlu1, I Erdoğan, S Eminağaoğlu, S C Karahan, S Ozgün, G Can, H Bozkaya.   

Abstract

This study was conducted to investigate the effectiveness of serum levels of free beta-hCG, progesterone, CA125 and their combined use in the prediction of first trimester abortions. A total of 140 singleton pregnant women between 5 and 13 weeks' gestational age were included as Group I (n = 21) who resulted in abortion including missed abortion, incomplete abortion, complete abortion and inevitable abortion; Group II (n = 129) included normal pregnancies. When using the free beta-hCG level of <20 ng/ml as a cut off point, the sensitivity, specificity, PPV and NPV were 91%, 82%, 46% and 98%, when using a progesterone of <15 ng/ml as a cut off point, they were 91%, 89%, 59%, 98%. The single measurement of free beta-hCG or progesterone levels can be useful in the prediction of first trimester spontaneous abortions, but using progesterone may be recommended since it has high availability and low cost.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20373934     DOI: 10.3109/01443611003605286

Source DB:  PubMed          Journal:  J Obstet Gynaecol        ISSN: 0144-3615            Impact factor:   1.246


  8 in total

1.  Performance of single serum progesterone in the evaluation of symptomatic first-trimester pregnant patients: a systematic review and meta-analysis.

Authors:  Bahareh Ghaedi; Wei Cheng; Sara Ameri; Khadeer Abdulkarim; Nicholas Costain; Ayesha Zia; Venkatesh Thiruganasambandamoorthy
Journal:  CJEM       Date:  2022-08-03       Impact factor: 2.929

2.  The Diagnostic Value of β-Human Chorionic Gonadotropin, Progesterone, and Ischemia-Modified Albumin and Their Combined Use in the Prediction of First Trimester Abortions.

Authors:  Mehmet A Osmanağaoğlu; S Caner Karahan; Turhan Aran; Süleyman Güven; Elif Turgut; Ahmet Menteşe; Hasan Bozkaya
Journal:  Int Sch Res Notices       Date:  2014-07-01

3.  A randomized double-blind controlled trial of the use of dydrogesterone in women with threatened miscarriage in the first trimester: study protocol for a randomized controlled trial.

Authors:  Diana Man Ka Chan; Ka Wang Cheung; Sofie Shuk Fei Yung; Vivian Chi Yan Lee; Raymond Hang Wun Li; Ernest Hung Yu Ng
Journal:  Trials       Date:  2016-08-17       Impact factor: 2.279

4.  Pregnancy-related complications and perinatal outcomes following progesterone supplementation before 20 weeks of pregnancy in spontaneously achieved singleton pregnancies: a systematic review and meta-analysis.

Authors:  Hanglin Wu; Songying Zhang; Xiaona Lin; Jing He; Shasha Wang; Ping Zhou
Journal:  Reprod Biol Endocrinol       Date:  2021-11-04       Impact factor: 5.211

5.  Progestogen for treating threatened miscarriage.

Authors:  Hayfaa A Wahabi; Amel A Fayed; Samia A Esmaeil; Khawater Hassan Bahkali
Journal:  Cochrane Database Syst Rev       Date:  2018-08-06

Review 6.  The Influence of Oral Dydrogesterone and Vaginal Progesterone on Threatened Abortion: A Systematic Review and Meta-Analysis.

Authors:  Hee Joong Lee; Tae Chul Park; Jae Hoon Kim; Errol Norwitz; Banghyun Lee
Journal:  Biomed Res Int       Date:  2017-12-17       Impact factor: 3.411

7.  Serum progesterone distribution in normal pregnancies compared to pregnancies complicated by threatened miscarriage from 5 to 13 weeks gestation: a prospective cohort study.

Authors:  Chee Wai Ku; John C Allen; Sze Min Lek; Ming Li Chia; Nguan Soon Tan; Thiam Chye Tan
Journal:  BMC Pregnancy Childbirth       Date:  2018-09-05       Impact factor: 3.007

8.  Baseline Levels of Serum Progesterone and the First Trimester Pregnancy Outcome in Women with Threatened Abortion: A Retrospective Cohort Study.

Authors:  Yongshi Deng; Chi Chen; Siyun Chen; Guanyan Mai; Xiuping Liao; He Tian; Wenli Liu; Shuling Ji; Ying Liu; Jie Gao; Songping Luo
Journal:  Biomed Res Int       Date:  2020-03-02       Impact factor: 3.411

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.